These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7516416)

  • 1. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.
    Blackman MJ; Scott-Finnigan TJ; Shai S; Holder AA
    J Exp Med; 1994 Jul; 180(1):389-93. PubMed ID: 7516416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.
    Guevara Patiño JA; Holder AA; McBride JS; Blackman MJ
    J Exp Med; 1997 Nov; 186(10):1689-99. PubMed ID: 9362529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
    Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
    Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1.
    Blackman MJ; Dennis ED; Hirst EM; Kocken CH; Scott-Finnigan TJ; Thomas AW
    Exp Parasitol; 1996 Jul; 83(2):229-39. PubMed ID: 8682191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.
    Uthaipibull C; Aufiero B; Syed SE; Hansen B; Guevara Patiño JA; Angov E; Ling IT; Fegeding K; Morgan WD; Ockenhouse C; Birdsall B; Feeney J; Lyon JA; Holder AA
    J Mol Biol; 2001 Apr; 307(5):1381-94. PubMed ID: 11292349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate.
    Pizarro JC; Chitarra V; Verger D; Holm I; Pêtres S; Dartevelle S; Nato F; Longacre S; Bentley GA
    J Mol Biol; 2003 May; 328(5):1091-103. PubMed ID: 12729744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conserved parasite serine protease processes the Plasmodium falciparum merozoite surface protein-1.
    Blackman MJ; Chappel JA; Shai S; Holder AA
    Mol Biochem Parasitol; 1993 Nov; 62(1):103-14. PubMed ID: 8114810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.
    Moss DK; Remarque EJ; Faber BW; Cavanagh DR; Arnot DE; Thomas AW; Holder AA
    Infect Immun; 2012 Mar; 80(3):1280-7. PubMed ID: 22202121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.
    Woehlbier U; Epp C; Kauth CW; Lutz R; Long CA; Coulibaly B; Kouyaté B; Arevalo-Herrera M; Herrera S; Bujard H
    Infect Immun; 2006 Feb; 74(2):1313-22. PubMed ID: 16428781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia.
    Spencer Valero LM; Ogun SA; Fleck SL; Ling IT; Scott-Finnigan TJ; Blackman MJ; Holder AA
    Infect Immun; 1998 Aug; 66(8):3925-30. PubMed ID: 9673281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.
    Blackman MJ; Heidrich HG; Donachie S; McBride JS; Holder AA
    J Exp Med; 1990 Jul; 172(1):379-82. PubMed ID: 1694225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion.
    Blackman MJ; Whittle H; Holder AA
    Mol Biochem Parasitol; 1991 Nov; 49(1):35-44. PubMed ID: 1723148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal.
    Lyon JA; Carter JM; Thomas AW; Chulay JD
    Mol Biochem Parasitol; 1997 Dec; 90(1):223-34. PubMed ID: 9497045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro.
    Chappel JA; Egan AF; Riley EM; Druilhe P; Holder AA
    Infect Immun; 1994 Oct; 62(10):4488-94. PubMed ID: 7927713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum.
    Egan AF; Chappel JA; Burghaus PA; Morris JS; McBride JS; Holder AA; Kaslow DC; Riley EM
    Infect Immun; 1995 Feb; 63(2):456-66. PubMed ID: 7822010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds.
    Egan A; Waterfall M; Pinder M; Holder A; Riley E
    Infect Immun; 1997 Aug; 65(8):3024-31. PubMed ID: 9234749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex.
    Trucco C; Fernandez-Reyes D; Howell S; Stafford WH; Scott-Finnigan TJ; Grainger M; Ogun SA; Taylor WR; Holder AA
    Mol Biochem Parasitol; 2001 Jan; 112(1):91-101. PubMed ID: 11166390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.
    Chappel JA; Holder AA
    Mol Biochem Parasitol; 1993 Aug; 60(2):303-11. PubMed ID: 7694147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.
    O'Donnell RA; de Koning-Ward TF; Burt RA; Bockarie M; Reeder JC; Cowman AF; Crabb BS
    J Exp Med; 2001 Jun; 193(12):1403-12. PubMed ID: 11413195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells.
    Pan W; Ravot E; Tolle R; Frank R; Mosbach R; Türbachova I; Bujard H
    Nucleic Acids Res; 1999 Feb; 27(4):1094-103. PubMed ID: 9927744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.